ANALYSIS OF CLINICAL DETERMINANTS DRIVING SAFETY AND EFFICACY OF CAMIDANLUMAB TESIRINE (ADCT‐301, CAMI) IN RELAPSED/REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL)
暂无分享,去创建一个
J. Radford | S. Horwitz | J. Wuerthner | J. Boni | A. Davies | A. Spira | T. Menne | P. Caimi | P. Fields | F. Samaniego | M. Hamadani | J. Feingold | H. Cruz | S. He | G. Collins